 LEXINGTON, Mass., Nov. 12, 2020 GLOBE NEWSWIRE -- LogicBio Therapeutics, Inc. Nasdaq:LOGC, a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery today announced senior member of management will be presenting at upcoming investor conferences 